Latest News

June 1, 2018


Amorsa Therapeutics Appoints Jeffrey Wiesen to Board of Directors

January 9, 2018


Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Oral Compositions of Ketamine and Related Compounds

June 28, 2017


Amorsa Therapeutics Featured in the June Issue of Life Science Leader Magazine